Angioimmunoblastic T-Cell Lymphoma and Clinical Manifestations
Yes, angioimmunoblastic T-cell lymphoma (AITL) characteristically causes both flu-like symptoms and fluctuating white blood cell counts as part of its core clinical presentation. 1
Flu-Like Symptoms in AITL
AITL presents with a constellation of systemic symptoms that mimic flu-like illness:
- Fever is a hallmark feature of AITL, occurring as part of the classic presentation alongside generalized lymphadenopathy 1
- B symptoms (fever, night sweats, weight loss) are extremely common and should prompt investigation for opportunistic infections as well as the underlying lymphoma 1
- Skin rashes frequently accompany the systemic symptoms, contributing to the flu-like presentation 1
- The disease creates what has been termed an "immunodysplastic syndrome" with exacerbated inflammatory response and immune dysregulation 2
These systemic manifestations result from the secretion of cytokines and chemokines (IL-6, IL-21, CXCL-13, VEGF) by the malignant T-follicular helper cells, which modulate complex interactions within the tumor microenvironment 2.
White Blood Cell Count Fluctuations
AITL causes variable and fluctuating white blood cell abnormalities through multiple mechanisms:
- Eosinophilia is frequently associated with AITL and can fluctuate during the disease course 1
- Peripheral blood involvement occurs in AITL, with documented cases showing peripheral blood plasmacytosis and variable lymphocyte counts 3
- Bone marrow infiltration is common, affecting hematopoiesis and causing cytopenias that may fluctuate 4, 3
- Autoimmune cytopenias can develop, including autoimmune hemolytic anemia and immune thrombocytopenia, which cause fluctuating blood counts 5
The white blood cell count may show paradoxical patterns—some patients present with leukopenia despite having a lymphoproliferative disorder, while others show elevated counts with eosinophilia 4, 3.
Critical Diagnostic Considerations
When evaluating a patient with flu-like symptoms and fluctuating WBC:
- AITL typically presents in advanced stage (III or IV) at diagnosis, with most patients showing systemic involvement 1, 4
- Associated findings that distinguish AITL from simple viral illness include: hepatomegaly or splenomegaly, polyclonal hypergammaglobulinemia, pleural effusion, and ascites 4, 3
- EBV-positive B cells are frequently present in the tumor microenvironment and should be assessed 1
- The median age at presentation is around 60 years, occurring mainly in older patients 1, 4
Important Clinical Pitfalls
- Do not dismiss persistent flu-like symptoms in older adults with lymphadenopathy and fluctuating blood counts as simple viral infection 4, 3
- Opportunistic infections must be excluded when B symptoms are present, as AITL patients have severe immune dysregulation and predisposition to recurrent infections 1, 2
- The differential diagnosis is broad, including viral infections, collagenosis, and adverse drug reactions—AITL has been called a "many-faced lymphoma" for this reason 2
- Autoimmune phenomena can complicate the clinical picture, with predisposition to autoimmunity being a characteristic feature of AITL 2
Prognosis and Urgency
The prognosis of AITL is poor, with 5-year overall survival around 30-40% even with aggressive treatment 2. Early diagnosis is crucial, as the disease follows an aggressive, potentially fatal course—one reported case resulted in death within 2 months of diagnosis 3. The median survival time ranges around 20 months, though some patients achieve long-term survival exceeding 10 years 4.